Marex Group (MRX) has secured the required consents from holders of its 6.404% Senior Notes due 2029 to amend the indenture, a key step in its proposed redomiciliation to Bermuda.

The consent win comes as the stock trades at US$53.20, with the share price return up 33.17% over 90 days and 40.22% year to date, while the 1 year total shareholder return is 20.87%. This suggests momentum has been building despite some recent short term share price weakness.

If you are looking beyond Marex Group after this restructuring update, this could be a good moment to broaden your search and uncover 20 top founder-led companies

With Marex Group posting a 20.87% 1 year total shareholder return but trading only about 7% below the average analyst price target, the key question is whether the stock is still undervalued or if markets already reflect expectations for future growth.

Most Popular Narrative: 6.9% Undervalued

With Marex Group trading at $53.20 against a widely followed fair value estimate of $57.13, the current setup hinges on how investors view its earnings potential under that narrative.

Significant investments in technology and scalable platforms are already yielding desk-level productivity gains, higher revenues per employee, and improved front-office efficiency, supporting further operating leverage and net margin expansion as the business grows.

Want to see what is really driving that valuation gap? The narrative leans on shifting revenue mix, rising margins, and a potential earnings profile that may look very different from today.

Result: Fair Value of $57.13 (UNDERVALUED)

However, this depends on acquisitions and complex structured products not backfiring as a result of tougher regulation, higher compliance costs, or any renewed governance and reputational concerns.

Another View: Cash Flows Paint A Tougher Picture

While analyst targets and earnings based fair value suggest Marex Group might be modestly undervalued, the Simply Wall St DCF model points the other way. On that cash flow view, the stock at $53.20 trades well above an estimated value of $42.13. This raises a simple question: are earnings expectations too optimistic, or are cash flow assumptions too tight?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Marex Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 48 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With the story pulling in different directions, this is the moment to look through the data yourself, weigh the trade offs, and see the full picture with 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If you stop at Marex Group, you risk missing other stocks that could fit your goals, so widen your search now with focused screeners built for serious investors.

• Zero in on companies that combine quality with attractive pricing using the 48 high quality undervalued stocks.
• Prioritise resilience by checking stocks that clear strict balance sheet checks through the solid balance sheet and fundamentals stocks screener (46 results).
• Spot potential up and comers before they hit the spotlight by running the screener containing 21 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.